Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, and Neil Bhowmick, Chief Scientific Officer...
ENV105 can potentially address resistance in a wide range of cancers as they become resistant to standard treatments. Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3499 | 23.0197368421 | 1.52 | 2.3 | 0.851 | 346390 | 1.0861253 | CS |
4 | 0.1699 | 9.99411764706 | 1.7 | 2.3 | 0.851 | 115115 | 1.24239537 | CS |
12 | 0.3499 | 23.0197368421 | 1.52 | 2.75 | 0.851 | 323319 | 1.97824875 | CS |
26 | -2.1301 | -53.2525 | 4 | 4 | 0.851 | 285932 | 1.96904848 | CS |
52 | -2.1301 | -53.2525 | 4 | 4 | 0.851 | 285932 | 1.96904848 | CS |
156 | -2.1301 | -53.2525 | 4 | 4 | 0.851 | 285932 | 1.96904848 | CS |
260 | -2.1301 | -53.2525 | 4 | 4 | 0.851 | 285932 | 1.96904848 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.